COVID Collateral: Where Do We Go for Truth?

The Cato Institute
01:31:24 Report Issue
Loading transcript... Click for full transcript

Chapters & Sections (67)

0:03 US Premiere of COVID-19 Documentary Discussion chapter 3
0:03 US Premiere of COVID-19 Documentary Discussion
2:05 American Premiere of Film Co Collateral
3:41 Covid-19 Origin and Science Suppression
5:55 Government Censorship of Dissenting COVID Opinions chapter 3
5:55 Censorship of Dissenting COVID-19 Opinions
7:30 Censorship and Cover Up of COVID Outbreak
9:12 Biography of Dr. Robert Redfield
10:33 Ryan Bourne Discusses Pandemic Response and Findings chapter 2
10:33 Ryan Bourne Discusses Pandemic Response and Research
12:55 Scientific Community and Free Speech
15:15 CDC Director's Lockdown Debate Reflections chapter 2
15:15 CDC Director Discusses Lockdowns and Public Health
17:16 Author Faces Backlash for Pandemic Theory
19:25 COVID-19 Lockdown Economic Costs and Benefits chapter 2
19:25 COVID-19 Lockdown Economic Costs and Benefits
21:22 Uncertainty and Failure in COVID-19 Policy Making
23:41 Doctors and Off-Label Use of Medications chapter 2
23:41 Off-Label Drug Use and Medical Research
26:10 Uncertainty in COVID-19 Vaccine Development
28:07 Pandemic Response and Vaccine Development chapter 3
28:07 Pandemic Response and Vaccine Development
29:53 Private Sector Develops COVID-19 Treatments
31:16 Off-Label Use of Medications in COVID-19
33:18 Pandemic Response and Lockdown Debates chapter 2
33:18 Pandemic Response and Economic Downturn
34:52 COVID-19 Response and Technological Advancements
37:31 Cost Benefit Analysis of Lockdown Policies chapter 2
37:31 Pandemic Policy and Economic Consequences
40:02 Public Health Mindset and COVID-19 Response
42:33 Mortality Rate and Wuhan Wet Market Misconceptions chapter 2
42:33 COVID-19 Origin and Misclassification Discussion
44:35 Early COVID-19 Transmission Misconceptions in US
47:01 Covid Response and Private Sector Involvement chapter 3
47:01 Covid Response and Diagnostic Testing
48:43 Criticism of Economists on Virus and Economy
50:15 Economic Consequences of Lockdowns and Pandemic
51:50 WHO Travel Screening Recommendations Criticized chapter 4
51:50 WHO Travel Screening Recommendations Criticized
53:39 US Restricts Air Travel from China
55:17 Travel Restrictions and COVID-19 Response
56:34 COVID-19 Policy and Intelligence Challenges
57:55 Wuhan Lab Incident in Early September 2019 chapter 2
57:55 Wuhan Lab Incident in Early September 2019
1:00:41 Manipulation of COVID-19 Vaccine Vector
1:02:37 Sweden's COVID-19 Response and Lockdowns chapter 3
1:02:37 Sweden's COVID-19 Response and Lockdowns
1:04:26 Understanding Herd Immunity in COVID-19
1:05:51 Immunity Patterns and Intubation Strategies
1:07:21 COVID-19 Replication Dynamics and Mortality Factors chapter 2
1:07:21 COVID-19 Replication Dynamics and Mortality Factors
1:09:16 Supreme Court Ruling on Social Media Censorship
1:12:04 Importance of Elderly Patient Consideration in Trials chapter 2
1:12:04 Concerns about Human Challenge Trials
1:13:55 Regaining Public Trust in Public Health Decisions
1:16:26 Leadership and Decision Making in Pandemic chapter 3
1:16:26 Leadership and Decision Making in Pandemic
1:18:10 Virologist's Perspective on COVID-19 Origins
1:19:50 COVID-19 Origin Debate and Scientific Disagreement
1:22:31 Pandemic Origin and Scientific Responsibility chapter 3
1:22:31 Pandemic Origin and Scientific Responsibility
1:24:14 Concerns Over Gain of Function Research
1:25:27 Gain of Function Research Debate and Safety Concerns
1:26:55 Biocontainment in Labs is Crucial chapter 3
1:26:55 Biocontainment in Labs is Crucial
1:28:53 Concerns about Lab Safety and Global Cooperation
1:30:10 Preparation for a Viral Respiratory Pandemic

Transcript

Loading transcript...